TOPICS

Go-to-Market Strategy for Digital Health & Telehealth

DIRECT ANSWER

A go-to-market (GTM) strategy is the plan a company uses to bring a product to its target market and drive adoption. It defines the ICP, value proposition, pricing, distribution channels, and sales motion. A GTM strategy coordinates marketing, sales, and product to generate revenue from a specific customer segment. For Digital Health & Telehealth companies, this matters because Clinical validation is the purchase gate that most digital health companies hit too late — health system and payer buyers require peer-reviewed evidence of clinical outcomes before committing enterprise contracts, meaning marketing must start building the evidence story at seed, not Series B.

What go-to-market strategy means for Digital Health & Telehealth

Digital health marketing that converts enterprise buyers requires a sequenced evidence narrative: peer-reviewed pilot data → reference health system customer in the buyer's region → EHR integration certification → ROI model built on the buyer's own population data. Skipping any step in this sequence loses the deal to a competitor who has it. For consumer telehealth, SEO on high-intent symptom and condition queries (structured as health content, not promotional copy) is the highest-ROI acquisition channel because health system search volumes are enormous and organic ranks persist. HIPAA BAA availability must be stated on the first marketing touchpoint — enterprise buyers screen for it before opening a case study.

For Digital Health & Telehealth teams the relevant marketing pains are: Clinical validation is the purchase gate that most digital health companies hit too late — health system and payer buyers require peer-reviewed evidence of clinical outcomes before committing enterprise contracts, meaning marketing must start building the evidence story at seed, not Series B; EHR integration with Epic, Cerner, or athenahealth is a prerequisite for clinical workflow adoption — any platform without a certified Epic App Orchard listing or Cerner Code partnership faces immediate disqualification from most health system RFPs; Consumer-facing telehealth markets have commoditized on price — differentiation on clinical quality, specialty breadth, and outcome data is the only defensible positioning as Amazon Clinic, CVS Health, and Walmart Health compete on distribution and brand; Reimbursement and coverage decisions are made by payers outside the vendor's control — a product that delivers clinical value but lacks CPT code reimbursement or payer coverage faces a perpetual adoption ceiling; Health system procurement moves through lengthy value analysis committee (VAC) reviews that require simultaneous clinical champion, IT security, compliance, legal, and finance sign-off before a purchase order is issued; Provider burnout and EHR documentation burden mean clinicians are hostile to any new technology that adds workflow steps — marketing must lead with time savings and workflow reduction, not feature breadth. HIPAA Privacy and Security Rules (BAA required with every enterprise customer); 21st Century Cures Act interoperability requirements (FHIR API compliance); FDA Software as a Medical Device (SaMD) regulations for diagnostic or clinical decision support tools; FTC Health Breach Notification Rule for consumer health data; state telehealth practice standards and prescribing regulations (vary by state — especially controlled substances post-COVID waiver expiration); CMS reimbursement coding accuracy in marketing claims; CCPA and state privacy laws for consumer health data not covered by HIPAA

Core Components of a GTM Strategy

A complete go-to-market strategy addresses six interconnected elements: (1) Ideal Customer Profile — the firmographic and behavioral attributes of the accounts most likely to buy and retain; (2) Value Proposition — the specific outcome delivered, quantified where possible ('reduce CAC by 30%' beats 'improve marketing efficiency'); (3) Pricing and Packaging — how value is metered and at what price points across segments; (4) Distribution Channels — the paths through which customers discover, evaluate, and purchase (direct sales, self-serve, partner/channel, marketplace); (5) Sales Motion — whether the model is product-led, sales-led, or hybrid, and what the handoff points are; (6) Launch Plan — sequenced activation across marketing, sales, and customer success with owned, earned, and paid media.

The ICP is the foundation. A common failure mode is defining the ICP too broadly ('mid-market SaaS companies') rather than precisely ('50–500-employee SaaS companies in North America where the VP of Marketing owns the demand gen budget and the company is post-Series A but pre-Series C'). Precision enables message specificity, channel targeting, and account prioritization — all of which improve CAC and win rates.

Running go-to-market strategy for Digital Health & Telehealth with Hadrian

Hadrian's agents apply go-to-market strategy across Health system and payer conferences (HIMSS, HLTH, ViVE, JP Morgan Healthcare Conference), Healthcare trade publications (Modern Healthcare, Health Affairs, NEJM Catalyst, Fierce Healthcare), Epic App Orchard, Cerner Code, and health system innovation program partnerships, Self-insured employer benefits channels (NBGH, Business Group on Health, broker/consultant networks), Clinical society and specialty organization partnerships (AHA, AMA, specialty colleges) for clinical credibility for Digital Health & Telehealth companies — tuned to Chief Digital Health Officer or VP of Digital Innovation at a health system; VP of Clinical Transformation or CMO-adjacent innovation lead; VP Benefits at a self-insured employer (500+ employees) seeking population health management tools; Chief Medical Officer or VP Clinical at a payer's value-based care division; at consumer telehealth, a VP Growth or CMO focused on patient acquisition and retention and run under your approval, alongside every other marketing function.

FAQ

Go-to-Market Strategy for Digital Health & Telehealth — common questions

How long does it take to build a go-to-market strategy?

A first-version GTM strategy for a new product can be drafted in 2–4 weeks with proper ICP research (5–10 customer interviews, win/loss analysis, competitive review). Execution begins immediately after. The strategy should be treated as a living document, reviewed quarterly against pipeline and retention data.

How does go-to-market strategy differ for Digital Health & Telehealth companies?

The fundamentals are the same, but Digital Health & Telehealth marketing carries specific constraints — Clinical validation is the purchase gate that most digital health companies hit too late — health system and payer buyers require peer-reviewed evidence of clinical outcomes before committing enterprise contracts, meaning marketing must start building the evidence story at seed, not Series B and HIPAA Privacy and Security Rules (BAA required with every enterprise customer); 21st Century Cures Act interoperability requirements (FHIR API compliance); FDA Software as a Medical Device (SaMD) regulations for diagnostic or clinical decision support tools; FTC Health Breach Notification Rule for consumer health data; state telehealth practice standards and prescribing regulations (vary by state — especially controlled substances post-COVID waiver expiration); CMS reimbursement coding accuracy in marketing claims; CCPA and state privacy laws for consumer health data not covered by HIPAA. Hadrian adapts execution to that context automatically.

BUILT BY HADRIAN'S AGENTS

This page was written by Hadrian — the autonomous CMO.

Hadrian runs every channel of your marketing on your live data. See it work on your brand.

Get early access